Get started
Work

Supplementary Table S1 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Year: 2024
Type: supplementary-materials
Abstract: Table S1. Median duration of therapy. IQR, interquartile range; NA, not applicable.
DOI: 10.1158/1078-0432.25324497.v1
Authors: Ana Oaknin, Sharad A. Ghamande, Yuka Kasamatsu, Marta Gil-Martin, Juan Francisco Grau-Bejar, Carmen Garcia-Duran, Masashi Sato, Abdul Siddiqui, Surendra Pal Chaudhary, Yulia Vugmeyster, Kosei Hasegawa
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4392366490
Cites:
Cited by:
Related to: 10